99 Technology companies based outside the US often view US patent enforcement as an exceptional escalation — a last-resort legal escalation. Within US markets, however, enforcement actions function differently. In practice, for companies whose principal markets, acquirers, and competitors operate in the US, enforcement decisions can be part of ordinary commercialization strategy. The US patent system rests on a disclosure-for-exclusivity exchange intended to promote innovation. The enforcement mechanisms that accompany the right to exclude are therefore not ancillary to the system, but one component of the balance it establishes. The US remains the most consequential forum for patent enforcement— and the environment has tilted in ways that can favor well‑prepared rights holders. Case filings increased in 2024-2025, design‑patent suits surged, and annual patent damages hit a decade‑high. Meanwhile, PTAB institution practices and venue dynamics continue to evolve, creating structured paths to early leverage and resolution for the parties who plan strategically. Where US markets determine enterprise value, the ability to capture market share — through licensing, negotiation, or litigation — directly affects valuation, pricing discipline, and bargaining leverage. Despite this, many non-US companies continue to evaluate enforcement using assumptions formed with different conceptions about the value of patents and US patent law. Those assumptions can materially affect licensing leverage, portfolio value, and strategic flexibility. Misconception #1: “US Patent Litigation Is Prohibitively Expensive” A common assumption is that enforcement requires committing to a multi-year, multi-million-dollar litigation budget from the outset. That scenario can occur, but it is no longer the default posture from which enforcement decisions are evaluated. Patent litigation unfolds in stages. Companies typically assess a matter through successive inflection points — pleadings, early discovery, claim construction, and dispositive motion practice — each refining expected value. Industry economic survey data indicates that disputes involving moderate exposure are frequently evaluated through claim construction at costs measured in the hundreds of thousands rather than full-trial figures, and many resolve through negotiated outcomes at still lower levels. Correspondingly, fee structures have evolved. Hybrid and contingent arrangements, portfolio enforcement programs, and third-party litigation funding distribute risk and convert litigation expense into investment analysis 1. These mechanisms do not eliminate cost; they change its character. The decision becomes whether projected recovery justifies staged investment, not whether a company can finance a full trial. This staged structure matters because most disputes never approach trial. Contemporary litigation analytics consistently show that the overwhelming majority of patent cases resolve through settlement or procedural rulings before adjudication. Litigation cost is therefore not binary; it is contingent and incremental. 1. Third-party funded patent litigation is an investment strategy in which an investor who is not named in a lawsuit agrees to provide funding to the plaintiff (the patent owner in this context) or to the plaintiff’s law firm in exchange for a portion of the proceeds if the lawsuit is successful. Third-party funded patent litigation is typically nonrecourse, meaning that if the lawsuit is not successful, the plaintiff or law firm does not have to repay the funding. Third-party funded patent litigation has increased significantly since 2019 and now accounts for a substantial proportion of all patent litigation. US — IP & PATENTS
RkJQdWJsaXNoZXIy MjgzNzA=